3rd COPOLAD II Annual Meeting National Drugs Observatories

Start date: 25/03/19
End Date: 29/03/19
Place: Prague, Czech Republic

At this third annual edition, the progress achieved by the four working groups is presented: Early Warning Systems; Studies to evaluate and validate scales and indicators of “Problematic Drug Use" (PDU); Production of National Drug Reports; and New Methods for Detecting and Confronting problematic use and new threats.

Operative Dimension

Code: 1.8.3
Year: 2019
Component: C1 - National Drugs Observatories
Execution Level: Finished
Activity Types: Event

Training course
Associated operational objectives: 0.1 - Establish the necessary operational bases to ensure the quality and coherence of the work to be performed and the necessary coordination and participation of all partners.
0.2 - Have adequate baseline information to: provide specificity to the contents and the actions planned in each component; meet initial expectations of each partner in relation to its participation in COPOLAD; and facilitate the programme evaluation.
0.3 - Ensure visibility of COPOLAD and its activities and disseminate the contents in the main political and professional forums in the field of drug policies to be held both internationally and in CELAC.
0.4 - Establish the necessary institutional contacts to avoid duplication with already developed initiatives and ensure synergies with ongoing initiatives, both within the EU and CELAC.
1.1 - Study and assess changes from C1 on the existing needs, to define specific final contents of foreseen activities under Component 1; adjusting them to different groups of countries, in order to establish and/or reinforce the role of National Drugs Observatories in CELAC countries
1.2 - Promote the establishment of sustainable information-sharing agreements between NAs, NDOs and other stakeholders in CELAC countries, which can provide key information to assess threats and deal effectively with the new psychoactive drugs.
1.3 - Test, develop or update evaluation and monitoring tools, processes and tasks, necessary to deepen the knowledge of the drugs situation in CELAC countries with well-established NDOs.
1.4 - Implement a sustainable bi-regional cooperation capacity building strategy focused on enhancing the reporting capacity of NDOs being in an early stage of development.
1.5 - Implement a cooperation capacity building strategy in key areas identified, with special focus on the assessment of rising trends of problematic use of specific drugs.
1.6 - Continue to develop training opportunities focused in building capacities for strategic planning and the use of monitoring methods and tools, which can be mutually complementary.
Indicators: The percentage of CELAC countries having a NDO, has increased, at least a 50% (from baseline situation).

Theoretical Dimension

Approaches

Participant Institutions

This is a restricted section for participants who attended this activity. Ask for your username and password sending an email to info@copolad.eu

If you already have an username and password, you must log in at My COPOLAD and return to this activity to see the restricted sections.

Participation

Participation for regions

Participation of countries for region

Participants

This is a restricted section for participants who attended this activity. Ask for your username and password sending an email to info@copolad.eu

If you already have an username and password, you must log in at My COPOLAD and return to this activity to see the restricted sections.

Programme

This is a restricted section for participants who attended this activity. Ask for your username and password sending an email to info@copolad.eu

If you already have an username and password, you must log in at My COPOLAD and return to this activity to see the restricted sections.

Press Release

33 countries participating in COPOLAD present in Prague progress in their National Drug Observatories

Prague, 25 March 2019. The 3^rd COPOLAD II Annual Meeting of National Drug Observatories brings together this week 60 officials and experts from National Drug Observatories (NDO) from 15 Latin American countries, 13 Caribbean countries and 5 European Union (EU) countries, maintaining the highest response to the call in the region. The Cooperation Programme between Latin America, the Caribbean and the European Union on Drugs Policies (COPOLAD), managed by FIIAPP, promotes this activity which will take place in Prague from 25 to 29 March.

The meeting is organised by COPOLAD in close collaboration with the National Monitoring Centre for Drugs and Addiction Office of the Government of the Czech Republic, the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and the Inter-American Observatory on Drugs (OID-CICAD). It presents the progress achieved between the Community of Latin American and Caribbean States (CELAC) and the EU, through the sharing of the results achieved in the framework of the working groups developed since 2016.

At the opening ceremony the welcoming words were given by Viktor Mravcik, Director of the National Monitoring Centre for Drugs and Addiction, as host country of the meeting; Marya Hynes, Acting Director of the Inter-American Drug Observatory (CICAD/OAS); Ana Gallegos, Head of Sector of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Germán García da Rosa, Director of the Area of Public Administration and Social Affairs of the International and Ibero-American Foundation for Public Administration and Policy (FIIAPP), and Teresa Salvador-Llivina, Director of COPOLAD.

COPOLAD promotes knowledge exchange and capacity-building of professionals at the National Drug Observatories.

Throughout this week, the progress achieved by the four working groups that were defined during the 1^st COPOLAD II Annual Meeting of National Drug Observatories in Jamaica in December 2016 is presented: Early Warning Systems; Studies to evaluate and validate scales and indicators of “Problematic Drug Use" (PDU); Production of National Drug Reports; and New Methods for Detecting and Confronting problematic use and new threats

In this space, the work carried out by each group, results, and progress achieved in the participating countries is shared, while various support instruments are presented for the implementation of these advances in all the countries that wish to incorporate them into their legal and institutional frameworks. The working groups have been made up of the majority of CELAC countries, with the contribution of EMCDDA, OID-CICAD, as well as European experts and reference countries.